Breast cancer research and treatment
-
Breast Cancer Res. Treat. · Jul 2014
Comment LetterSentinel lymph node identification rates and axillary concordance can only be accurately determined by comparing 'like with like' injected materials.
Despite the accepted status of sentinel lymph node biopsy (SLNB) as the standard for axillary staging in breast cancer patients with clinically and radiologically negative axillae pre-operatively, there is surprisingly still a lack of consensus on the most appropriate site of injection of radioactive tracer with or without blue dye. ⋯ The only way to determine the optimal injection site of radioactive tracer and blue dye for SLN identification intra-operatively and accurate concordance rates is by direct comparisons of 'like with like' when it comes to injected materials at different injection sites.